Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting September 6th, 2022.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Cigna
Symbol: CI
Recent CI Stock Price: $288.04
Average Analyst Price Target: n/a (9.63%)
CI Market Cap: $86.49B
Expected Ex-Dividend Date for CI stock: Sep 06 2022
Expected Payment Date for CI stock: Sep 22 2022
Expected Dividend & Yield for CI stock: 1.49%
Recent Analyst Action: Ricky Goldwasser, analyst at Morgan Stanley, reiterates coverage on Cigna (CI) stock in the Healthcare sector with a Buy rating and a price target of $ 318 (2 weeks ago).
TipRanks.com also reports that Cigna stock currently has 18 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $315.78 . The target pricing ranges from a high forecast of $350.00 down to a low forecast of $270.00. Cigna (CI)’s last closing stock price was $288.04 which would put the average price target at 9.63% upside.Here are 3rd party ratings for CI stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 35% (89 out of 252)
--------------------------------------------------------------------------
CSL
Symbol: CMXHF
Recent CMXHF Stock Price: $198.5
Average Analyst Price Target: n/a (11.19%)
CMXHF Market Cap: $96.31B
Expected Ex-Dividend Date for CMXHF stock: Sep 06 2022
Expected Payment Date for CMXHF stock: Oct 05 2022
Expected Dividend & Yield for CMXHF stock: 1.14%
Recent Analyst Action: Gretel Janu, analyst at Credit Suisse, reiterates coverage on CSL (CMXHF) stock in the Healthcare sector with a Hold rating and a price target of $ 207.74 (2 weeks ago).
TipRanks.com also reports that CSL stock currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $346.67 . The target pricing ranges from a high forecast of $360.00 down to a low forecast of $325.00. CSL (CMXHF)’s last closing stock price was $198.5 which would put the average price target at 11.19% upside.Here are 3rd party ratings for CMXHF stock:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: n/a
--------------------------------------------------------------------------
Phibro Animal Health
Symbol: PAHC
Recent PAHC Stock Price: $15.3
Average Analyst Price Target: n/a (40.52%)
PAHC Market Cap: $599.86M
Expected Ex-Dividend Date for PAHC stock: Sep 06 2022
Expected Payment Date for PAHC stock: Sep 28 2022
Expected Dividend & Yield for PAHC stock: 3.10%
Recent Analyst Action: Erin Wright, analyst at Morgan Stanley, reiterates coverage on Phibro Animal Health (PAHC) stock in the Healthcare sector with a Hold rating and a price target of $ 21 (6 days ago).
TipRanks.com also reports that Phibro Animal Health stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $21.50 . The target pricing ranges from a high forecast of $22.00 down to a low forecast of $21.00. Phibro Animal Health (PAHC)’s last closing stock price was $15.3 which would put the average price target at 40.52% upside.Here are 3rd party ratings for PAHC stock:
- TipRanks.com: Moderate Sell
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Bottom 37% (159 out of 252)
--------------------------------------------------------------------------
Steris
Symbol: STE
Recent STE Stock Price: $200.22
Average Analyst Price Target: n/a (19.62%)
STE Market Cap: $20.14B
Expected Ex-Dividend Date for STE stock: Sep 06 2022
Expected Payment Date for STE stock: Sep 23 2022
Expected Dividend & Yield for STE stock: 0.87%
Recent Analyst Action: Chris Cooley, analyst at Stephens, reiterates coverage on Steris (STE) stock in the Healthcare sector with a Buy rating and a price target of $ 250 (4 weeks ago).
TipRanks.com also reports that Steris stock currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $239.50 . The target pricing ranges from a high forecast of $250.00 down to a low forecast of $225.00. Steris (STE)’s last closing stock price was $200.22 which would put the average price target at 19.62% upside.Here are 3rd party ratings for STE stock:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 41% (149 out of 252)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
